Cow's milk protein allergy in children: a practical guide

Carlo Caffarelli1, Francesco Baldi, Barbara Bendandi

  • 1Dipartimento dell'Età Evolutiva, Clinica Pediatrica Università di Parma, Parma, Italy. carlo.caffarelli@unipr.it

Insights

This guide offers best practices for diagnosing and managing cow's milk allergy in children. It provides a unified approach for healthcare professionals, detailing immediate and delayed allergic reactions.

Area of Science:

  • Pediatric Allergy and Immunology
  • Gastroenterology

Background:

  • Cow's milk allergy (CMA) is a common condition in infants and children.
  • Varied diagnostic and management approaches exist, leading to inconsistencies in care.

Purpose of the Study:

  • To establish best practices for the diagnosis, management, and follow-up of CMA in children.
  • To create a common, evidence-based approach for pediatric specialists and primary care physicians.

Main Methods:

  • A joint study group comprising pediatric allergologists and gastroenterologists was formed.
  • The group convened multiple times to discuss and reach a consensus on diagnostic and management strategies.

Main Results:

  • Identified immediate symptoms of CMA including urticaria, angioedema, wheezing, and anaphylaxis.
  • Detailed late-onset symptoms such as atopic dermatitis, chronic diarrhea, iron deficiency anemia, and poor growth.
  • Included diagnostic methods and proposed three distinct algorithms for CMA diagnosis and follow-up based on symptoms and infant diet.

Conclusions:

  • A consensus was reached on key areas of CMA diagnosis and management.
  • The developed guide provides a standardized framework for healthcare providers to improve care for children with CMA.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...